VAPA
Vesicle-associated membrane protein-associated protein A
Also known as: hVAP-33, VAP-A, VAPA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P0L0
- Gene
- VAPA
- Ensembl
- ENSG00000101558
- Chromosome
- 18
- Canonical length
- 249 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a type IV membrane protein. It is present in the plasma membrane and intracellular vesicles. It may also be associated with the cytoskeleton. This protein may function in vesicle trafficking, membrane fusion, protein complex assembly and cell motility. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
249 residues, UniProt reviewed canonical sequence.
>Q9P0L0|VAPA
1 MASASGAMAK HEQILVLDPP TDLKFKGPFT DVVTTNLKLR NPSDRKVCFK VKTTAPRRYC
61 VRPNSGIIDP GSTVTVSVML QPFDYDPNEK SKHKFMVQTI FAPPNTSDME AVWKEAKPDE
121 LMDSKLRCVF EMPNENDKLN DMEPSKAVPL NASKQDGPMP KPHSVSLNDT ETRKLMEECK
181 RLQGEMMKLS EENRHLRDEG LRLRKVAHSD KPGSTSTASF RDNVTSPLPS LLVVIAAIFI
241 GFFLGKFILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VAPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 92 nTPM
- skeletal muscle: 64 nTPM
- adrenal gland: 60 nTPM
- esophagus: 43 nTPM
- pancreas: 39 nTPM
- blood vessel: 38 nTPM
Single-cell type
- esophageal apical cells: 1,110 nCPM
- neutrophils: 981 nCPM
- basal keratinocytes: 567 nCPM
- syncytiotrophoblasts: 552 nCPM
- platelets: 496 nCPM
- suprabasal keratinocytes: 493 nCPM
Immune cell
- eosinophil: 252 nTPM
- neutrophil: 227 nTPM
- total PBMC: 184 nTPM
- classical monocyte: 144 nTPM
- basophil: 134 nTPM
- intermediate monocyte: 128 nTPM
Brain region
- pons: 79 nTPM
- cerebellum: 71 nTPM
- white matter: 68 nTPM
- medulla oblongata: 68 nTPM
- spinal cord: 65 nTPM
- midbrain: 62 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about VAPA.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 50 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide transport
- cholesterol transport
- COPII-coated vesicle budding
- endoplasmic reticulum to Golgi vesicle-mediated transport
- endoplasmic reticulum-plasma membrane tethering
- host-mediated activation of viral genome replication
- host-mediated suppression of viral genome replication
- membrane fusion
- neuron projection development
- phospholipid transport
- positive regulation of canonical NF-kappaB signal transduction
- protein localization to endoplasmic reticulum
- sphingomyelin biosynthetic process
- sterol transport
- viral release from host cell
Molecular functions
- cadherin binding
- FFAT motif binding
- microtubule binding
- protein domain specific binding
- protein heterodimerization activity
- protein homodimerization activity
- protein-membrane adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VAPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VAPA as an antibody target. Whether an autoantibody or antibody against VAPA could matter depends on whether native VAPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VAPA is annotated at the cell surface, where native VAPA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label VAPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...